Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temodal in Anaplastic Oligodendroglioma
NCT00003465Phase 2Completed
- Sponsor
- Duke University
- Start
- Mar 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in anaplastic oligodendroglioma (AO), sponsored by Duke University. Started Mar 1998; status: completed.
02
Drugs
temozolomide
03
Conditions
anaplastic oligodendroglioma (AO)
Beyond the preview
Go deeper on NCT00003465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003465.